Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,791
Closed -$1.25M 38
2025
Q2
$1.25M Buy
3,791
+1,655
+77% +$533K 0.23% 81
2025
Q1
$703K Sell
2,136
-220
-9% -$66.3K 0.15% 108
2024
Q4
$650K Sell
2,356
-24
-1% -$7.65K 0.14% 103
2024
Q3
$787K Sell
2,380
-259
-10% -$89.2K 0.19% 91
2024
Q2
$873K Buy
2,639
+21
+0.8% +$7.24K 0.2% 91
2024
Q1
$951K Buy
2,618
+423
+19% +$139K 0.24% 85
2023
Q4
$657K Buy
2,195
+125
+6% +$36.5K 0.19% 100
2023
Q3
$592K Sell
2,070
-368
-15% -$105K 0.19% 96
2023
Q2
$685K Sell
2,438
-65
-3% -$16.9K 0.17% 124
2023
Q1
$640K Buy
2,503
+297
+13% +$86.5K 0.17% 126
2022
Q4
$582K Sell
2,206
-35
-2% -$11.1K 0.17% 130
2022
Q3
$617K Buy
2,241
+34
+2% +$9.57K 0.18% 124
2022
Q2
$580K Buy
2,207
+70
+3% +$18K 0.17% 130
2022
Q1
$507K Sell
2,137
-323
-13% -$75.6K 0.12% 163
2021
Q4
$565K Sell
2,460
-39
-2% -$8.29K 0.13% 152
2021
Q3
$502K Buy
2,499
+192
+8% +$41.7K 0.13% 167
2021
Q2
$540K Buy
2,307
+435
+23% +$109K 0.14% 161
2021
Q1
$452K Buy
1,872
+201
+12% +$44.8K 0.12% 171
2020
Q4
$347K Buy
+1,671
New +$328K 0.1% 194
2020
Q2
$204K Buy
+1,088
New +$206K 0.08% 192
2020
Q1
Sell
-998
Closed -$201K 209
2019
Q4
$201K Buy
+998
New +$183K 0.07% 215

Other funds holding CI

Summit X LLC's CI Position: Q3 2025 in Review

Summit X LLC sold out of Cigna (CI) in Q3 2025, closing a stake of 3,791 shares — an estimated $1.25M sold.

Summit X LLC first reported a position in CI in Q4 2019 and held it in 21 quarters. The position peaked at $1.25M in Q2 2025. 1,618 funds tracked by Wall St. Rank hold CI as of Q3 2025.

  • Summit X LLC reported no remaining Cigna position as of Q3 2025 after selling out during the quarter.
  • Summit X LLC sold 3,791 Cigna shares in Q3 2025, an estimated $1.25M.
  • Summit X LLC first reported a position in Cigna in Q4 2019 and held it in 21 quarters.
  • Summit X LLC's Cigna position peaked at $1.25M in Q2 2025.
  • 1,618 funds tracked by Wall St. Rank held Cigna as of Q3 2025.

Based on Summit X LLC's 13F filing for Q3 2025.